Year: 2018

Integrated Behavioral Health, Inc. Announces the Acquisition of Inflexxion, Inc.

COSTA MESA, Calif., July 10, 2018 ( – Integrated Behavioral Health, Inc. (“IBH”), today announced the acquisition of Inflexxion, Inc. (“Inflexxion” or the “Company”), a healthcare data and analytics company that specializes in the collection, surveillance, monitoring and analysis of critical public health issues including prescription drug abuse, substance use, behavioral health, and pain management…. Read more »

PainCAS partners with Allscripts to make software available to EHR users

Pain and opioid risk assessment featuring SOAPP® & COMM® to be available through Allscripts Developer Program WALTHAM, Mass., July 2, 2018  — Inflexxion, Inc. announced today that its pain and opioid risk assessment software, PainCAS, is being featured as the Allscripts Developer Program (ADP) July app of the month.  PainCAS enables Allscripts ambulatory EHR users to… Read more »

A New Strategy for Combating the Opioid Epidemic

The Department of Health and Human Services (HHS) recently released their 5-point strategy for combating the opioid crisis. The strategy outlines the elements the HHS deems most important in targeting the epidemic at its source and ending the fight for the many thousands still struggling. The team here at Inflexxion is working to help achieve… Read more »

Inflexxion is presenting at the CPDD Scientific Meeting

Inflexxion is presenting at the CPDD Scientific Meeting from June 9-14 at the Hilton San Diego Bayfront in San Diego, CA. We will be presenting our poster titled “Development of a Qualitative Coding Methodology to Assess Motivations for Use of Suboxone Film.”   The College on Problems of Drug Dependence is the longest standing group in the United… Read more »

Marijuana: a dangerous, addictive drug or relief for pain patients?

Marijuana was valued for its healing powers in many ancient cultures. In ancient Greece, cannabis cured inflammation. In India, it was offered as a cure for leprosy. In China, it was used for just about everything. By 1850, marijuana was listed in the United States Pharmacopeia and was considered acceptable for use in curing many… Read more »

Disability Claimants and the Implementation of a Web-Based Pain Assessment/Pain Management Program

How important is a pain management program in the clinical setting? Recently, Inflexxion partnered with Aetna Disability to answer this question, exploring the impact of using a clinical assessment system and pain management resources with disability claimants as part of a pain management program. Two of Inflexxion’s tools were implemented, PainCAS Clinical Assessment System, a… Read more »

Inflexxion is exhibiting at the American Society of Addiction Medication (ASAM) conference

Inflexxion is exhibiting at the American Society of Addiction Medicine conference at the Hilton San Diego Bayfront in San Diego, CA from April 12-15. Visit our booth, #607 to learn more about our behavioral health product suite.  This includes the Addiction Severity Index Multimedia Version (ASI-MV), our evidence-based, consumer self-administered assessment tool for behavioral health… Read more »

Webinar: Streamline the assessment process in your medication assisted treatment program

Click  here to register today! Join us on Thursday, March 29 at 1pm EST to learn how to streamline the assessment process in your medication assisted treatment program using the Addiction Severity Index Multimedia Version (ASI-MV) and Behavioral Health Index Multimedia Version (BHI-MV) evidence-based tools. These client self-administered behavioral health solutions gather data in a standardized… Read more »

Your questions about the COMM-9 answered

►What is the COMM-9? The COMM-9 is an evidence-based electronically administered clinical screening tool intended to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. It is a brief version of the Current Opioid Misuse Measure (COMM). The COMM and COMM-9 were developed with guidance from pain and addiction experts and… Read more »

Inflexxion to exhibit at the American Association for Treatment of Opioid Dependence conference

Inflexxion is exhibiting at the American Association for the Treatment of Opioid Dependence conference from March 10-14 at the New York Marriot Marquis in New York, NY. Visit us at booth #711 to learn more about our addiction treatment products, the ASI-MV product suite, as well as our opioid risk assessment, PainCAS. The American Association for the Treatment of… Read more »